- Home
- AQST vs CPS Comparison
AQST vs CPS Comparison
Compare AQST & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | CPS |
|---|---|---|
| Founded | 2004 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 475.9M |
| IPO Year | 2007 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AQST | CPS |
|---|---|---|
| Price | $4.63 | $21.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | $9.33 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 2.1M | 235.9K |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.87 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $12.09 | $3.86 |
| Revenue Next Year | $35.73 | $4.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $20.25 |
| 52 Week High | $7.55 | $47.98 |
Technical Indicators
Market Signals| Indicator | AQST | CPS |
|---|---|---|
| Relative Strength Index (RSI) | 47.09 | 38.87 |
| Support Level | $4.51 | $20.25 |
| Resistance Level | $4.69 | $31.24 |
| Average True Range (ATR) | 0.22 | 1.00 |
| MACD | -0.04 | 0.09 |
| Stochastic Oscillator | 28.36 | 38.11 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.